Norofert Q1 2025 Results: 19% revenue growth and a net profit of over RON 5 million. Revenue and profit growth in the USA subsidiary.

 

Bucharest, May 23^rd, 2025 – Norofert, the leading producer of organic agricultural inputs and biotechnology provider for agriculture in Romania, listed on the AeRO market of the Bucharest Stock Exchange (BVB symbol: NRF), recorded a turnover of RON 13.9 million in the first quarter of 2025, an increase of approximately 19% compared to the same period of the previous year. The company continues its profitable trajectory started in 2024, recording a net profit of over RON 5 million in Q1 2025, in the context of revenues generated on the USA market, as well as new contracts signed in Romania and underway in Q1 and Q2 2025. This performance was supported by cost optimization measures and strict financial discipline, in a challenging market environment characterized by a lack of liquidity in Romanian agribusiness.

 

Vlad Popescu, President of the Board, Norofert:

„The strong results recorded in the first quarter of 2025 reflect the healthy development path the company is on, in a year of strategic significance for Norofert. In the upcoming period, we will mark the start of production at our Brazil facility, built on an operational model already successfully validated the USA. We recorded an EBITDA margin of over 50% at group level and revenues exceeding RON 1.2 million in the USA, results that confirm the effectiveness of our strategic decisions. Research and development remain central pillars of our sustainable growth. The laboratory in Filipeștii de Pădure, where we are developing our own microorganism strain bank, gives us a significant competitive edge in an ever-evolving industry. This innovation capacity enables us to tailor our product portfolio to the specific needs of each market. We are focused on strengthening our presence in the USA and Brazil—two strategic markets that have the potential to generate up to 40% of the Group’s turnover in the next three years.”

 

The new investment in Chapeco – Brazil is expected to start generating revenues in the second half of the year. In 2025, the company estimates that the two factories on the American continent will generate approximately 7% of the Group’s total revenue.

 

Key consolidated figures for Q1 2025:

• Fixed assets: RON 28.6 million, up by over 14%, mainly due to investments in the research laboratory and irrigation system, essential elements for strengthening the company’s competitive position.
• Total liabilities: RON 4 million, a 20% increase, primarily because of investments in foreign markets, higher financing costs, and supplier advances.
• Operating revenues: RON 14.8 million, an increase of 16%, reflecting higher sales.
• Operating expenses: RON 7.8 million, a decrease of 34% following operational efficiency measures and reduced goods-related expenses, due to the procurement of raw materials in the fall of 2024.
• Operating result: RON 7 million, 8 times higher.
• Net profit: RON 5.3 million, compared to RON 1.414 in Q1 2024, supported by the production and sales of agricultural inputs, as well as by the performance in the USA market.

 

 

 

The financial results are presented according to RAS (Romanian Accounting Standards) and under IFRS (International Financial Reporting Standards). The group’s consolidated results include the performance of the parent company, Norofert S.A., as well as that of the 100% owned subsidiary Agroprod CEV S.R.L. Agroprod CEV cultivates 1,000 hectares of agricultural land under organic management in Zimnicea, Teleorman County. The consolidation also includes 51% of the results from NOROFER AG LLC.

 

The detailed report can be consulted here.

 

 

About Norofert:

 

Norofert is the leader in regenerative agriculture research and one of the largest producers of inputs in Romania, founded in 2000 by the Popescu family. While expanding the production facilities to support sustainable agricultural practices internationally, Norofert demonstrates a commitment to climate neutrality and the ability to innovate in an area crucial to the future of agriculture and food security.

 

With a mix of business lines, Norofert has developed its production capacities in recent years in inputs and agricultural farming, lines that will see development in the coming years. With 65 products in its portfolio, the company caters to conventional and organic farmers, with a new niche of liquid conventional products in growing demand.

 

Since  2020, the company has been listed on the Bucharest Stock Exchange’s AeRO market, and from October 2021, Norofert shares are included in the BETAeRO index. During the five years of activity in the capital market, Norofert raised RON 14 million through capital increases and RON 18.5 million through a private placement of corporate bonds. The company’s corporate bonds are traded​ ​on the AeRO market of the Bucharest Stock Exchange under the symbol NRF29 starting January 27th, 2025.

For more information, we invite you to visit www.norofert.ro.